Last reviewed · How we verify

Azo Gantrisin (sulfafurazole)

Alra · FDA-approved active Quality 38/100

Azo Gantrisin (generic name: sulfafurazole) is a Sulfonamide Antimicrobial drug developed by Alra. It is currently FDA-approved (first approved 1971) for Acute otitis media, Chancroid, Chlamydia Cervicitis.

Azo Gantrisin, also known as sulfafurazole, is a sulfonamide antimicrobial drug developed by ALRA. It targets the endothelin-1 receptor and is used to treat various bacterial infections, including otitis media, chancroid, and meningococcal meningitis. The drug is a small molecule with a bioavailability of 96% and a half-life of 7.4 hours. It was FDA-approved in 1971 and is currently owned by ALRA. As a sulfonamide antimicrobial, Azo Gantrisin works by inhibiting bacterial growth and replication.

At a glance

Generic namesulfafurazole
SponsorAlra
Drug classSulfonamide Antimicrobial
TargetEndothelin-1 receptor
Therapeutic areaImmunology
PhaseFDA-approved
First approval1971

Approved indications

Common side effects

No common side effects on file.

Drug interactions

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
FDA labelMechanism, indications, dosing, boxed warnings, drug interactions
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Azo Gantrisin

What is Azo Gantrisin?

Azo Gantrisin (sulfafurazole) is a Sulfonamide Antimicrobial drug developed by Alra, indicated for Acute otitis media, Chancroid, Chlamydia Cervicitis.

What is Azo Gantrisin used for?

Azo Gantrisin is indicated for Acute otitis media, Chancroid, Chlamydia Cervicitis, Chlamydial conjunctivitis, Falciparum malaria.

Who makes Azo Gantrisin?

Azo Gantrisin is developed and marketed by Alra (see full Alra pipeline at /company/alra).

What is the generic name of Azo Gantrisin?

sulfafurazole is the generic (nonproprietary) name of Azo Gantrisin.

What drug class is Azo Gantrisin in?

Azo Gantrisin belongs to the Sulfonamide Antimicrobial class. See all Sulfonamide Antimicrobial drugs at /class/sulfonamide-antimicrobial.

When was Azo Gantrisin approved?

Azo Gantrisin was first approved on 1971.

What development phase is Azo Gantrisin in?

Azo Gantrisin is FDA-approved (marketed).

What does Azo Gantrisin target?

Azo Gantrisin targets Endothelin-1 receptor and is a Sulfonamide Antimicrobial.

Related